DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity
Claire Vanpouille-Box, Amandine Alard, Molykutty J. Aryankalayil et al. · 2017
Read DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity by Claire Vanpouille-Box, Amandine Alard, Molykutty J. Aryankalayil et al. (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-5472757.txt.
Description
Vanpouille-Box, Alard, Aryankalayil, and their colleagues reported in 2017 on radiotherapy and tumor immunity. Researchers are testing whether radiotherapy can make immunotherapy work better. The mechanisms by which radiation induces anti-tumor T cells, though, remained unclear.
The team shows that an enzyme called Trex1, a DNA exonuclease, is induced by radiation doses above a certain threshold in different cancer types. Trex1 chews up the DNA debris that would otherwise alert the immune system. That finding explains why dose per treatment matters for immune effects. It guides how radiation schedules should be designed when the goal is to partner with immunotherapy.
Catalog record
| CREATOR | Claire Vanpouille-Box, Amandine Alard, Molykutty J. Aryankalayil et al. |
|---|---|
| YEAR | 2017 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 47 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PubMed Central |